About Labderm s.c.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Eli Lilly and Company
2
Clinical Trials at Labderm s.c.
During the past decade, Labderm s.c. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.
2020-02-03
2021-09-16
Completed
228
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)
2020-06-15
2024-09-30
Active, not recruiting
1,000
A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
2021-04-06
2022-04-21
Completed
52
A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial
2021-07-27
2024-04-29
Active, not recruiting
45
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Labderm s.c."
#1 collaborator was "Dermira, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Labderm s.c.
According to Clinical.Site data, the most researched conditions in "Labderm s.c." are
"Atopic Dermatitis" (2 trials) and "Hidradenitis Suppurativa" (2 trials). Many other conditions were trialed in "Labderm s.c." in a lesser frequency.
Clinical Trials Intervention Types at Labderm s.c.
Most popular intervention types in "Labderm s.c." are "Biological" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Lebrikizumab" (2 trials), "Placebo" (2 trials), "Spesolimab" (2 trials) and "Topical Corticosteroid" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Labderm s.c.
The vast majority of trials in "Labderm s.c." are
4 trials for "All" genders.
Clinical Trials Status at Labderm s.c.
Currently, there are NaN active trials in "Labderm s.c.".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Labderm s.c.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Labderm s.c., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".